Company Profile (AI Text)
Name: Global Cancer Technology
Canonical URL: https://wefunder.com/global.cancer.technology
Updated at: 2026-06-04T23:53:55Z

Tagline: Developing a novel drug to treat glioblastoma brain cancer and triple-negative breast cancer

Key claims:
- Total raised on Wefunder: 0 | citation: https://wefunder.com/global.cancer.technology#claim-total-raised
- Total investors: 0 | citation: https://wefunder.com/global.cancer.technology#claim-total-investors

Verified facts:
- Total raised on Wefunder: 0 | observed_at: 2026-06-04T23:53:55Z | expires_at: 2026-06-05T23:53:55Z
- Total investors: 0 | observed_at: 2026-06-04T23:53:55Z | expires_at: 2026-06-05T23:53:55Z

Computed metrics:
- total_amount_raised: 0
- total_investors: 0
- team_size: 1
- featured_investor_count: 10
- faq_count: 0
- recent_post_count: 0

Quick facts:
- We have shown that our drug can make glioblastoma tumors completely disappear in lab mice | citation: https://wefunder.com/global.cancer.technology#claim-fact-1
- Research partners are Baylor University, Brown, University of Colorado , Mayo clinic and others | citation: https://wefunder.com/global.cancer.technology#claim-fact-2
- We have been prove equal to better than a similar drug entering a phase 111 clinical trial | citation: https://wefunder.com/global.cancer.technology#claim-fact-3
- Research will soon show us as the leading promising drug for children's glioblastoma, or DIPG | citation: https://wefunder.com/global.cancer.technology#claim-fact-4
- Preclinical studies have shown us to outperform Alpelisib, a breast cancer FDA-approved drug | citation: https://wefunder.com/global.cancer.technology#claim-fact-5
- Outstanding Scientific and Business advisory board | citation: https://wefunder.com/global.cancer.technology#claim-fact-6